COMSTOCK HOLDING COMPANIES (CHCI)

US2056842022 - Common Stock

9.64  +0.17 (+1.8%)

Fundamental Rating

6

Overall CHCI gets a fundamental rating of 6 out of 10. We evaluated CHCI against 68 industry peers in the Real Estate Management & Development industry. Both the health and profitability get an excellent rating, making CHCI a very profitable company, without any liquidiy or solvency issues. CHCI has a correct valuation and a medium growth rate.



9

1. Profitability

1.1 Basic Checks

In the past year CHCI was profitable.
CHCI had a positive operating cash flow in the past year.
Each year in the past 5 years CHCI has been profitable.
In the past 5 years CHCI always reported a positive cash flow from operatings.

1.2 Ratios

CHCI has a Return On Assets of 11.70%. This is amongst the best in the industry. CHCI outperforms 97.01% of its industry peers.
With an excellent Return On Equity value of 14.64%, CHCI belongs to the best of the industry, outperforming 95.52% of the companies in the same industry.
CHCI's Return On Invested Capital of 13.39% is amongst the best of the industry. CHCI outperforms 97.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHCI is significantly above the industry average of 5.17%.
The last Return On Invested Capital (13.39%) for CHCI is well below the 3 year average (17.96%), which needs to be investigated, but indicates that CHCI had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROIC 13.39%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%

1.3 Margins

With an excellent Profit Margin value of 13.44%, CHCI belongs to the best of the industry, outperforming 86.57% of the companies in the same industry.
In the last couple of years the Profit Margin of CHCI has grown nicely.
CHCI's Operating Margin of 15.74% is amongst the best of the industry. CHCI outperforms 86.57% of its industry peers.
In the last couple of years the Operating Margin of CHCI has grown nicely.
The Gross Margin of CHCI (21.03%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHCI is creating value.
The number of shares outstanding for CHCI has been increased compared to 1 year ago.
Compared to 5 years ago, CHCI has more shares outstanding
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CHCI has an Altman-Z score of 2.88. This is not the best score and indicates that CHCI is in the grey zone with still only limited risk for bankruptcy at the moment.
CHCI has a better Altman-Z score (2.88) than 70.15% of its industry peers.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.88
ROIC/WACC1.48
WACC9.05%

2.3 Liquidity

A Current Ratio of 2.88 indicates that CHCI has no problem at all paying its short term obligations.
CHCI's Current ratio of 2.88 is fine compared to the rest of the industry. CHCI outperforms 71.64% of its industry peers.
A Quick Ratio of 2.88 indicates that CHCI has no problem at all paying its short term obligations.
CHCI has a Quick ratio of 2.88. This is in the better half of the industry: CHCI outperforms 76.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 2.88

4

3. Growth

3.1 Past

The earnings per share for CHCI have decreased strongly by -16.19% in the last year.
CHCI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.50% yearly.
CHCI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
Measured over the past years, CHCI shows a very strong growth in Revenue. The Revenue has been growing by 22.22% on average per year.
EPS 1Y (TTM)-16.19%
EPS 3Y45.5%
EPS 5YN/A
EPS Q2Q%-49.97%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Sales Q2Q%-10.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

CHCI is valuated correctly with a Price/Earnings ratio of 16.07.
CHCI's Price/Earnings ratio is rather cheap when compared to the industry. CHCI is cheaper than 85.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.96. CHCI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.07
Fwd PE N/A

4.2 Price Multiples

94.03% of the companies in the same industry are more expensive than CHCI, based on the Enterprise Value to EBITDA ratio.
97.01% of the companies in the same industry are more expensive than CHCI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.91
EV/EBITDA 9.84

4.3 Compensation for Growth

The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (11/21/2024, 8:19:23 PM)

9.64

+0.17 (+1.8%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap95.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.07
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.88
Quick Ratio 2.88
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-16.19%
EPS 3Y45.5%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y